Today's Date: June 3, 2023
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting   •   GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting   •   LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemo   •   Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Cl   •   Bijou Ikli named new CEO by Florida Assisted Living Association   •   San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y   •   High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf   •   UNice Celebrates LGBTQ Pride Month   •   New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing   •   Government of Canada releases summary of actions taken to address the safety and wellbeing of Indigenous women, girls and 2SLGBT   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin   •   Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery   •   KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i   •   Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award
Bookmark and Share

30+ Health Leaders Explore Strategies to Ease Hospital-to-Home Patient Transitions

SAN FRANCISCO , March 26 /Businesswire/ - The Healthcare Logistics Think Tank / Do Tank (HLTT/DT), the healthcare industry’s only organization centered on improving healthcare logistics, will host the meeting, “Logistics Enabled Transitions: Synchronizing Discharge to Remote Patient Management,” which will convene 30+ healthcare leaders during ViVE 2023. The cost of unplanned readmissions is $15 - $20 billion annually and this meeting will reveal novel logistics solutions and strategies to improve the post-discharge patient experience. The March 28th meeting may be attended in Zoom or in-person at Vanderbilt University Medical Center (VUMC). KLAS will publish the findings.

Optimized logistics support efficient healthcare delivery, but they remain elusive. Healthcare systems are prioritizing logistics, but no single entity can tackle these challenges. The HLTT/DT is a non-commercial group of 16 healthcare systems, 45 healthcare service and technology companies and three professional societies, which meet 7-10 times annually for candid discussion about improving hospital efficiency and patient care. The March 28 meeting will focus on the continuum of patient needs post hospital discharge, including accountability for patients, pharmacy integration and remote patient management.

“Logistic challenges are far too complex for any one solution provider to tackle,” said Bob Krinsky, co-founder of HLTT/DT. “We join the world’s most accomplished healthcare leaders to exchange ideas, accelerate innovation and ultimately raise the bar for the healthcare ecosystem.”

The meeting will feature speakers from VUMC, Biofourmis, and Omnicell and takes place from 1:00 pm – 2:30 CDT. Email to register. Free transportation for local and ViVE participants is available.

About the Healthcare Logistics Think Tank / Do Tank

The Healthcare Logistic Think Tank / Do Tank (HLTT/DT), is a virtual, non-commercial platform to exchange ideas, advance multi-vendor partnerships, and promote proofs of concept for better outcomes and performance. HLTT/DT members meet regularly to discuss pressing challenges, share lessons learned and debate strategies, looking beyond traditional supply chain and IT to better synchronize the movement of data, devices and people across and beyond the enterprise. Conceived by The Krinsky Company, a “top ten healthcare consulting company,” HLTT/DT is funded by its members. Learn more: The Future Of Health Care Logistics, visit the website and follow HLTT on LinkedIn.

STORY TAGS: United States, North America, Professional Services, Public Policy/Government, Health, Healthcare Reform, Thought Leadership, Hospitals, Practice Management, California, Webcast, Conference, Product/Service, Event,


White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News